I 
113TH CONGRESS 
1ST SESSION H. R. 2433 
To amend the Public Health Service Act to provide for human stem cell 
research, including human embryonic stem cell research, and for other 
purposes. 
IN THE HOUSE OF REPRESENTATIVES 
JUNE 19, 2013 
Ms. DEGETTE (for herself and Mr. DENT) introduced the following bill; which 
was referred to the Committee on Energy and Commerce 
A BILL 
To amend the Public Health Service Act to provide for 
human stem cell research, including human embryonic 
stem cell research, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Stem Cell Research 
Advancement Act of 2013’’. 
SEC. 2. FINDINGS. 
The Congress finds as follows: 
(1) On March 9, 2009, President Barack 
Obama issued Executive Order 13505, entitled ‘‘Re-
VerDate Mar 15 2010 
23:32 Jun 24, 2013
Jkt 029200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H2433.IH
H2433
smartinez on DSK6TPTVN1PROD with BILLS
moving Barriers to Responsible Scientific Research 
Involving Human Stem Cells’’. 
(2) On July 7, 2009, the National Institutes of 
Health issued guidelines on human stem cell re-
search. 
(3) The scientific field of stem cell research is 
continually advancing. 
SEC. 3. HUMAN STEM CELL RESEARCH. 
Part H of title IV of the Public Health Service Act 
(42 U.S.C. 289 et seq.) is amended by inserting after sec-
tion 498D the following: 
‘‘SEC. 498E. HUMAN STEM CELL RESEARCH. 
‘‘(a) IN GENERAL.—Notwithstanding any other pro-
vision of law, the Secretary shall conduct and support re-
search that utilizes human stem cells, including human 
embryonic stem cells. 
‘‘(b) ELIGIBILITY.—To be eligible for use in research 
under subsection (a), human embryonic stem cells must 
have been derived from cells from human embryos that— 
‘‘(1) were created using in vitro fertilization for 
reproductive purposes and are no longer needed for 
those purposes; and 
‘‘(2) were donated by the individuals who 
sought reproductive treatment with written and vol-
untary informed consent for the embryos to be used 
VerDate Mar 15 2010 
23:32 Jun 24, 2013
Jkt 029200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H2433.IH
H2433
smartinez on DSK6TPTVN1PROD with BILLS
for research purposes and without receiving any fi-
nancial or other inducements to make the donation. 
‘‘SEC. 498F. GUIDELINES. 
‘‘The Secretary, in consultation with the Director of 
NIH, shall— 
‘‘(1) maintain guidelines applicable to the con-
duct or support of human stem cell research by the 
Department of Health and Human Services; 
‘‘(2) review such guidelines not less than every 
3 years; and 
‘‘(3) update such guidelines as scientifically 
warranted. 
‘‘SEC. 498G. PROHIBITION AGAINST FUNDING FOR HUMAN 
CLONING. 
‘‘(a) PROHIBITION.—The Secretary shall not use any 
funds for the conduct or support of human cloning. 
‘‘(b) GUIDELINES.—The Secretary shall update the 
guidelines maintained under section 498F for consistency 
with subsection (a). 
‘‘(c) DEFINITIONS.—In this section, the term ‘human 
cloning’ means the implantation of the product of trans-
ferring the nuclear material of a human somatic cell into 
an egg cell from which the nuclear material has been re-
moved or rendered inert into a uterus or the functional 
equivalent of a uterus.’’. 
VerDate Mar 15 2010 
23:32 Jun 24, 2013
Jkt 029200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H2433.IH
H2433
smartinez on DSK6TPTVN1PROD with BILLS
SEC. 4. REPORTING REQUIREMENTS. 
Section 403(a)(5) of the Public Health Service Act 
(42 U.S.C. 283(a)(5)) is amended— 
(1) by redesignating subparagraph (L) as (M); 
and 
(2) by inserting after subparagraph (K) the fol-
lowing: 
‘‘(L) Human stem cells.’’. 
Æ 
VerDate Mar 15 2010 
23:32 Jun 24, 2013
Jkt 029200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\H2433.IH
H2433
smartinez on DSK6TPTVN1PROD with BILLS